Helius Medical Technologies Inc [HSDT] stock is trading at $0.55, up 47.02%. An important factor to consider is whether the stock is rising or falling in short-term value. The HSDT shares have gain 15.30% over the last week, with a monthly amount drifted -33.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Helius Medical Technologies Inc [NASDAQ: HSDT] stock has seen the most recent analyst activity on March 24, 2021, when Noble Capital Markets initiated its Outperform rating and assigned the stock a price target of $20.
Helius Medical Technologies Inc [HSDT] stock has fluctuated between $0.37 and $9.50 over the past year. Helius Medical Technologies Inc [NASDAQ: HSDT] shares were valued at $0.55 at the most recent close of the market.
Analyzing the HSDT fundamentals
Helius Medical Technologies Inc [NASDAQ:HSDT] reported sales of 0.59M for the trailing twelve months, which represents a drop of -28.91%. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -20.35%, Pretax Profit Margin comes in at -14.88%, and Net Profit Margin reading is -14.88%. To continue investigating profitability, this company’s Return on Assets is posted at -1.0, Equity is -2.58 and Total Capital is -1.78. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4538 points at the first support level, and at 0.3575 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6030, and for the 2nd resistance point, it is at 0.6559.
Ratios To Look Out For
For context, Helius Medical Technologies Inc’s Current Ratio is 4.20. On the other hand, the Quick Ratio is 3.80, and the Cash Ratio is 3.11. Considering the valuation of this stock, the price to sales ratio is 3.34, the price to book ratio is 0.28.
Transactions by insiders
Recent insider trading involved ANDREEFF DANE, President and CEO, that happened on Dec 14 ’23 when 5000.0 shares were purchased. President and CEO, ANDREEFF DANE completed a deal on Dec 01 ’23 to buy 2006.0 shares. Meanwhile, President and CEO ANDREEFF DANE bought 2000.0 shares on Nov 30 ’23.
